Oxycodone/Naloxone Ratiopharm (Naloxone Hydrochloride, Oxycodone Hydrochloride)

Oxycodone, the active ingredient in Oxycodone/Naloxone Ratiopharm, is an opioid analgesic presented as a oral tablet for oral use. It treats moderate to severe pain in adult patients requiring around-the-clock opioid therapy. GNH USA supplies Oxycodone/Naloxone Ratiopharm as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxycodone/Naloxone Ratiopharm as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone/Naloxone is an opioid analgesic combined with an opioid antagonist used for managing pain that follows:

- Chronic non‑cancer pain: Provides sustained relief while reducing opioid‑induced constipation. - Cancer‑related pain: Offers strong analgesia for severe pain associated with malignancy. - Post‑operative pain: Controls acute pain after major surgery when strong opioid therapy is required. - Opioid‑induced bowel dysfunction (OIBD) prevention: Limits the development of constipation due to opioid treatment. - Long‑term opioid therapy : Helps maintaining pain control with lower risk of gastro‑intestinal side‑effects.

Side effects may vary in frequency and severity.

Common Side Effects: - Nausea and vomiting: Frequent gastrointestinal upset. - Constipation: Reduced bowel motility, mitigated by naloxone. - Dizziness: Light‑headedness or vertigo. - Somnolence: Drowsiness or fatigue. - Dry mouth: Reduced salivation. - Headache: Mild to moderate cranial pain.

Serious or Rare Side Effects: - Respiratory depression: Marked reduction in breathing rate. - Severe hypotension: Dangerous drop in blood pressure. - Allergic reactions: Rash, itching, swelling, or anaphylaxis. - Seizures: Uncommon but serious neurologic events. - Hepatic impairment: Liver function abnormalities. - Adrenal insufficiency: Hormonal imbalance affecting stress response.

When using Oxycodone/Naloxone, several precautions should be considered:

- Assess  : Evaluate the patient for risk of respiratory depression and addiction before treatment. - Concomitant : Avoid the any other opio ​   "); - Con  ");  """  """. -  ");  ". " """ """ """ "" 

"  " ". -  " ". - " "  "" ");  "" ",